Suxamethonium apnoea

Print this article
Share this page:


  1. The total activity for the cholinesterase enzyme in blood is measured, also known as butyrylcholinesterase.
  2. A cholinesterase phenotype for the patient is also reported as this will enable the doctor to predict the likelihood of suxamethonium apnoea. The phenotype is a study of the characteristics of the enzyme activity and is determined by the effect of a range of compounds that inhibit the cholinesterase enzyme
  3. If a phenotype is difficult to confirm or there is an atypical type in the immediate family, genotype studies which identify the inherited genes should be considered.

« Prev | Next »